Statistical inference and causal reasoning in observational health data
The application of statistical methods and causal inference frameworks to non-randomized health data (e.g., electronic health records, claims data) to estimate treatment effects and understand mechanisms, while rigorously accounting for confounding and bias.
This skill enables organizations to generate real-world evidence for drug efficacy, safety, and value-based care decisions, directly impacting regulatory submissions, market access, and clinical practice. It transforms passive data repositories into active strategic assets for reducing R&D costs and accelerating time-to-market.
1Careers
1Categories
9.0 Avg Demand
15%
Avg AI Risk
How to Learn Statistical inference and causal reasoning in observational health data
1. Master foundational statistics: probability distributions, hypothesis testing, and linear/logistic regression. 2. Learn core causal concepts: confounding, selection bias, DAGs (Directed Acyclic Graphs), and the distinction between correlation and causation. 3. Gain proficiency in basic data wrangling and analysis in R or Python using health data formats (e.g., OMOP CDM).
1. Move to practical application by implementing common causal inference methods: propensity score matching/weighting, instrumental variables, and difference-in-differences. 2. Focus on critical scenario: analyzing a treatment effect from an observational study, identifying and mitigating key biases like immortal time bias. 3. Avoid the common mistake of using overly complex models before clearly defining the causal question and assessing data suitability.
1. Master advanced methods: target trial emulation, g-computation, doubly robust estimators, and handling time-varying confounding. 2. Develop expertise in structuring complex problems: aligning causal questions with business strategy (e.g., comparative effectiveness for formulary decisions). 3. Mentor teams on validating methods, sensitivity analysis, and effectively communicating uncertainty to non-technical stakeholders.
Practice Projects
Beginner
Project
Propensity Score Analysis for a Simple Treatment Effect
Scenario
Using a publicly available dataset (e.g., from NHANES or a sample EHR dataset), estimate the effect of a binary exposure (e.g., statin use) on a binary outcome (e.g., high LDL) while adjusting for measured confounders like age, sex, and BMI.
How to Execute
1. Data Preparation: Load data, define exposure, outcome, and confounders. Perform basic cleaning. 2. Propensity Score Model: Fit a logistic regression model to predict treatment assignment based on confounders. 3. Matching or Weighting: Use the propensity score to create matched pairs or inverse probability weights (IPW). 4. Outcome Analysis: Compare outcomes between treated and control groups in the matched/weighted sample and interpret the Average Treatment Effect (ATE).
Intermediate
Project
Target Trial Emulation for a New Diabetes Medication
Scenario
Design and implement a target trial emulation using observational claims data to compare the cardiovascular safety of a newly marketed GLP-1 receptor agonist to an existing SGLT2 inhibitor in patients with type 2 diabetes.
How to Execute
1. Protocol Specification: Precisely define eligibility criteria, treatment strategies, outcome of interest (e.g., MACE), and follow-up period, mirroring a hypothetical RCT. 2. Data Construction: Extract and structure data from an OMOP CDM database, handling time-zero alignment and ensuring no prior outcome events. 3. Analysis: Implement a Cox proportional hazards model with inverse probability of treatment weighting (IPTW) to adjust for a comprehensive list of baseline confounders. 4. Sensitivity Analyses: Conduct quantitative bias analysis for unmeasured confounding and test robustness to different modeling choices.
Advanced
Case Study/Exercise
Advising a Pharma Market Access Team on Real-World Evidence
Scenario
A pharmaceutical company has just received a negative HTA (Health Technology Assessment) decision for its new oncology drug due to weak comparative effectiveness evidence against a competitor. You are tasked with designing a new RWE study to support a re-submission in 6 months.
How to Execute
1. Causal Question Reframing: Collaborate with medical affairs to refine the research question to address the specific HTA committee's doubts (e.g., effect in a real-world subpopulation). 2. Methodological Blueprint: Select an advanced method like g-estimation for time-varying confounding if the treatment pattern is dynamic. Justify this choice to the HTA body. 3. Execution & Validation: Oversee the analytical team's implementation, focusing on rigorous validation of data integrity and model assumptions. 4. Communication Strategy: Prepare a transparent report detailing the methodology, limitations, and a structured dialogue with the HTA committee to address their concerns.
Tools & Frameworks
Software & Platforms
R (tidyverse, MatchIt, WeightIt, survival, lmtest)Python (statsmodels, causalml, DoWhy)OMOP Common Data Model (CDM) & OHDSI Tools (ATLAS, SQL)
R and Python are the primary languages for implementation. Specialized packages (e.g., MatchIt for matching, causalml for ML-based causal inference) are essential. The OMOP CDM and OHDSI toolkit provide the standardized infrastructure and tools for reproducible, large-scale observational studies.
The Potential Outcomes framework defines causal effects precisely. Structural Causal Models, operationalized via DAGs, are used to identify adjustment sets and sources of bias. The Target Trial Emulation framework is the gold-standard for protocol design to avoid common observational study pitfalls.
Propensity scores are workhorses for confounding adjustment. IVs handle unmeasured confounding when a valid instrument exists. DiD is key for policy/program evaluation. G-methods are advanced approaches for time-varying treatments and confounding.
Interview Questions
Answer Strategy
Structure the answer using the Target Trial Emulation framework. 1) Define the protocol components. 2) Identify key biases: confounding by indication (doctors prescribe Drug A to sicker patients), immortal time bias, and measurement error. 3) Specify mitigation: use a new-user cohort design with active comparator, apply IPTW using a rich set of baseline covariates, and define time-zero correctly. Mention sensitivity analyses for unmeasured confounding.
Answer Strategy
The interviewer is testing critical thinking, methodological rigor, and ability to communicate skepticism constructively. The core competency is evaluating internal validity. The answer should systematically list potential biases (selection, confounding, time-related) and propose a methodical approach to verification.
Careers That Require Statistical inference and causal reasoning in observational health data